Detroit automakers are seeing third-quarter revenue gains, led by a 2.9% rise at General Motors, as average new vehicle transaction prices hold near record highs at just over $50,000. These gains are being undermined by steep commodity tariffs, elevated diesel prices averaging $6.35 per gallon, and intense multi-industry competition for memory chips. Major producers now face billions in direct headwinds, prompting firms like Ford to lean on growth, parts, and software services to offset the financial impact.
Key points
Tariffs on imported metals combined with high fuel prices are creating multi-billion-doll…: Tariffs on imported metals combined with high fuel prices are creating multi-billion-dollar headwinds for major American automakers.
Rising global demand for electric vehicles and data centers is intensifying competition a…: Rising global demand for electric vehicles and data centers is intensifying competition and driving up prices for copper.
Automakers are attempting to offset rising manufacturing costs through business growth, s…: Automakers are attempting to offset rising manufacturing costs through business growth, spare parts, and software-based services.
Sources checked by our analysis pipeline: 1
Sign up for the Planet Money newsletter. The world is confusing. Economics can help.
American automakers are reporting their third quarter earnings, and they're saying revenues are up, but they're also facing some serious headwinds.
Or as Mike Wall, an analyst at the automotive data company Mobility Global, put it: If this year was a book about the auto industry, "It would be a mix of suspense and thrills and maybe a little bit of comedy and a little bit of horror."
For the thrills: Auto companies are doing well when it comes to selling big cars and light-duty trucks. General Motors reported its sales of light-duty trucks rose 9% in the past year. Ford's F-Series trucks continue to be a company bestseller. Stellantis' pickup sales in the U.S. rose 34%.
And revenues overall are up: General Motors reported its revenue was up 2.9% in the past year; for Ford it was a 2% rise and Stellantis was up 1%.
To analysts, all of this signals that consumers are still buying vehicles — despite concerns about affordability. The average new…
Wall Street expects the pharmaceutical giant to post $22.61 billion in revenue, powered by strong demand for its flagship diabetes and obesity treatments. These record profits have provided capital for an aggressive acquisition push into vaccines and psychedelic medicine. Investors are closely monitoring whether this momentum will maintain the company's edge over key rival Novo.
The strategic governance restructuring aligns with the company's shift toward an independent, board-led management structure. Independent director Sudarshan Sampathkumar will step into the non-executive chairman post, while Sanjay Sachdeva maintains executive leadership as managing director and chief executive. This planned evolution arrives on the heels of a corporate financial turnaround that prompted positive market sentiment.